Randomization. The Manufacturing Computer shall utilize randomizing procedures in the creation of the Subsets. The randomizing procedures shall be in accordance with Section 6 of this Appendix.
Randomization. Each work period, the random lists shall be compiled by placing each eligible employee’s name into a selection device. Once all names have been deposited, they shall be mixed. After mixing is complete, each name shall be selected one at a time by the Superintendent or his designee. The first name selected shall be placed on the top of the work assignment list, and so forth.
Randomization. 62 Long-term effectiveness of computer-generated tailored patient education Single-tailored letter (N=278) Multiple-tailored letter (N=310) Standard letter (N=273) 1 month Interview Another letter 1 month Interview Another letter 12 months Interview Another letter Interview Another letter 1 month 12 months 1 month Nsingle=163 Posttest (Ntotal=508) Nmultiple=186 Nstandard=159 Randomization 166 were excluded: • 124 just quit • 42 did not fill in questionnaire properly 187 did not attend Questionnaires sent back to Leiden University (N=861) Questionnaires sent by General Practitioner (N=4000) Chapter 5 Figure 1 Flow diagram Recruitment Chronic benzodiazepine users were recruited via thirty general practitioners throughout the Netherlands. The general practitioners were originally randomly selected from an electronic version of the Dutch telephone directory and received €200 compensation for their participation. The general practitioners were phoned and asked how many chronic benzodiazepine users they had in their patient database. Five general practitioners declined participation on behalf of certain of their patients. The reported reasons for declining Long-term effectiveness of computer-generated tailored patient education 63 were that patients had severe co-morbidity or psychosocial problems. As a consequence, an estimated fifty patients were excluded. The general practitioners’ assistants forwarded packages to their chronic benzodiazepine users. The packages contained, firstly, an informed consent form. Secondly, they contained one A4 sheet of information in which the procedure was explained. Thirdly, a pre-test questionnaire was added in order to produce the (first) tailored letter. Lastly, a prepaid envelope was added so that the patient could return the informed consent form and the questionnaire to the researcher. Four thousand packages were sent to patients using benzodiazepines. The patients who returned the pre-test questionnaires were randomly assigned to one of the three conditions. The data on the participants in the tailored interventions were imported into the computer program, which produced the tailored letters. All letters were sent to the participants within one week. The additional two subsequent letters in the multiple tailored intervention were each based on a separate individual assessment through a standardized telephone interview of a maximum of ten minutes. The post-test questionnaire was sent out after twelve months. The tailored i...
Randomization. The PI and/or a member of the research team will review medical records and results of OGTT prior to randomization to exclude subjects with contraindications (see eligibility criteria: section IV.B.2). Eligible patients will be randomized into a lifestyle intervention or a standard of care group. A blocked randomization will be based on body weight – overweight (BMI 25-<30 kg/m2) and obese (BMI > 30 kg/m2), using the randomly permuted blocks method in a set of 4 sequential enrolled patients per group. Content of Educational Sessions. Monthly in-person education sessions are adapted from the Prevent T2, a CDC modified program from the original DPP (Knowler et al., 2002) and will cover the following topics: 1) healthy eating, 2) being active, 3) monitoring weight and physical activity, 4) stress management, 5) problem solving, and 6) healthy coping. Personal and group educational sessions will be led by a bilingual CDC certified lifestyle coach. Lifestyle Intervention Program. The linguistically lifestyle intervention will consist of a monthly 60 minutes in-person group educational sessions and biweekly telephone booster calls, which will continue until 3 months after delivery. Participants will attend their regularly scheduled obstetric clinic visits, usually every 4 weeks until the 28th weeks then every 2 weeks until the 35th week of pregnancy and weekly thereafter until delivery. If a participant develops a significant maternal complication, she will be withdrawn from the study and referred for follow up and management by the maternal-fetal specialists. Participants who develop GDM will be referred to the specialist and if specialist agrees, participant will continue participation and followed and monitored until post-delivery period. Participants will receive information on the appropriate weight gain during pregnancy using the IOM guidelines. At each intervention in-group session, the participant’s weight will be measured using a balance beam scale and recorded. The CDC trained lifestyle coach will inform the participant whether her weight gain is at the appropriate recommended level. If her weight gain is within the IOM guidelines, the patient will be encouraged to continue current eating and exercise regimen. If her weight gain is not within the IOM guidelines, the participant’s eating and exercise regimen will be reviewed by the coordinator and the lifestyle coach and she will be advised to increase or decrease her intake and increase or decrease her...
Randomization. An IWRS will be utilized to randomize patients 1:1 to bardoxolone methyl or placebo. Randomization will be stratified by number of background PAH therapies: 0, 1, or 2.
Randomization. Centrally administered randomization stratified by clinical center, diabetes status, and blocked by calendar time.
Randomization. A complete randomization scheme will be applied with a 1 levosimendan : 1 placebo allocation ratio. The complete randomization scheme will eliminate the possible bias due to predictability of treatment assignment.58
Randomization. The PI and/or a member of the research team will review medical records and results of OGTT prior to randomization to exclude subjects with contraindications (see eligibility criteria: section IV.B.2). Eligible patients will be randomized into a lifestyle intervention or a standard of care group. A blocked randomization will be based on body weight – overweight (BMI 25-<30 kg/m2) and obese (BMI > 30 kg/m2), using the randomly permuted blocks method in a set of 4 sequential enrolled patients per group.
Randomization. You will be assigned to a treatment program by chance, and the treatment you receive may not work as well or have more side effects than the other study treatment(s) or other available treatments. Washout period: You [will/may] receive no medication, or medication at a dose which may not help your condition. As a result, you [will/may] have an increase in symptoms including [XX].
Randomization. Subjects will be randomized to receive either standard of care (SOC) treatment (no topical therapy for 24 hours post fractional RF treatment) or a topical adjuvant combination treatment utilizing SCR Complex™ and Bio Cel™. The order of treatment will be assigned to subjects through subject number. All subjects will resume skin care as per VenusSkin protocol 24 hours post fractional RF treatments.
